Metabolomics Market by Application: Biomarker Discovery, Drug Discovery,Functional Genomics | Waters Corporation, Agilent Technologies

The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period.

ReportsnReports added Metabolomics Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Metabolomics Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Metabolomics Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=214354

Top Company Profile Analysis in this Report- Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US), Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US)

The report segments the metabolomics market based on region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa), product & service (metabolomics instruments ((separation tools (((gas chromatography, high-performance liquid chromatography, ultra-performance liquid chromatography, and capillary electrophoresis))), detection tools (((nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and surface-based mass analysis))), bioinformatics tools and services) application (biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications), indication (cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and other indications),end user(academic and research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users). Company type (Tier 1, tier 2, Tier 3 providers of metabolomics instruments and services). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the metabolomics market.

The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing use of metabolomics in toxicology testing are driving the growth of the global metabolomics industry. However, issues related to data examination & data processing in metabolomics and the high cost of tools and instruments are likely to restrain the market growth to a certain extent.

The metabolomics instrument segment is expected to account for the largest market share in 2020. Factors such as the technological advancements in analytical instruments in terms of miniaturization, automation, and computerization; increase in the number of research-related activities worldwide in the field of medicine, nutraceuticals, and metabolomics; and strengthening healthcare infrastructure in developing nations for efficient disease diagnosis and treatment are expected to propel the growth of this segment during the forecast period

The biomarker discovery segment is expected to account for the largest market share in 2020. The use of metabolic biomarkers to assess the pathophysiological health status of patients is increasing. In recent years, as a result of significant technological advancements, metabolomics has become a vital tool in discovering biomarkers.

Based on indication, the metabolomics market has been segmented into into cancer, cardiovascular disorders, neurological disorders, metabolic disorders, inborn errors of metabolism, and other indications (respiratory and infectious diseases. The cancer segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing number of patients who have cancer and the subsequent increase in the demand for cancer therapies.

The academic and research institutes segment accounted for the largest share of the metabolomics market in 2020. The increasing number of research activities in the field of metabolomics and funding to the academic and research institutes to conduct metabolomics research are the factors responsible for the largest share of the segment.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.

North America, which includes the US and Canada, accounted for the largest share of the metabolomics market. The large share of the North America region can be attributed to the presence of major players operating in the metabolomics market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.

Breakdown of primaries-
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

By Respondent– Supply Side- 80%, Demand Side-20%
By Designation— Executives- 25%, CXOs- 20%, Managers - 55%
By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%

Single User License: US $ 4950 
Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=214354

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the metabolomics market and provides them information on key market drivers, challenges, and opportunities.

Table Of Contents in this Report-
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Global Metabolomics Market Segmentation
1.3.2 Years Considered For The Study
1.4 Currency 
1.5 Limitations
1.6 Stakeholders
1.7 Summary Of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 2 Breakdown Of Primaries: Metabolomics Market
2.1.3 Market Data Estimation & Triangulation
2.1.4 Data Triangulation
Figure 3 Data Triangulation Methodology
2.2 Market Estimation Methodology
Figure 4 Market Size Estimation (Company Revenue Analysis-Based Estimation)
Figure 5 Metabolomics Market Size (Usd Million)
Figure 6 Metabolomics Market: Growth Rate Of Top Companies (2018−2019)
Figure 7 Metabolomics Market: Final Cagr Projections (2020−2025)
Figure 8 Metabolomics Market: Cagr Projections From The Analysis Of Demand-Side Drivers And Opportunities
2.3 Industry Insights
2.4 Assumptions For The Study

3 Executive Summary
Figure 9 Metabolomics Market Share, By Product & Service, 2019 Vs. 2025 (Usd Million)
Figure 10 Metabolomics Market Share, By Application, 2019
Figure 11 Metabolomics Market Size, By Indication, 2020 Vs. 2025
Figure 12 Geographical Snapshot Of The Metabolomics Market

4 Premium Insights
4.1 Metabolomics Market Overview
Figure 13 Increasing Pharmaceuticals R&D Activities And Growing Demand For Personalized Medicine Will Favor Market Growth
4.2 Asia Pacific: Metabolomics Market Share, By Product And Service And By Country (2019)
Figure 14 Metabolomics Instruments Segment Accounted For Larger Share Of Asia Pacific Market In 2019
4.3 Metabolomics Market Size, By Detection Tools
Figure 15 Mass Spectrometry (Ms) Segment Will Continue To Dominate The Market
4.4 Metabolomics Market Share, By Separation Tools, 2020 Vs. 2025
Figure 16 Hplc Holds The Largest Share Of The Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 17 Metabolomics Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Key Market Drivers
5.2.1.1 Availability Of Government And Private Funding For Metabolomics Research
5.2.1.2 Increasing Pharmaceutical And Biotech R&D Expenditure
5.2.1.3 Growing Demand For Personalized Medicine
5.2.2 Key Market Restraints
5.2.2.1 Issues Related To Data Examination And Processing
5.2.2.2 High Cost Of Tools And Instruments
5.2.3 Key Market Opportunities
5.2.3.1 Biomarker Development
5.2.3.2 Lucrative Opportunities In Emerging Markets
5.2.4 Key Market Challenges
5.2.4.1 Complexity And Diversity Of Biological Samples
5.2.4.2 Dearth Of Skilled Researchers
5.3 Impact Of Covid-19 On Growth Of Metabolomics Market

6 Industry Insights

and more...

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.